- Home
- AMH vs NBIX Comparison
AMH vs NBIX Comparison
Compare AMH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMH
- NBIX
- Stock Information
- Founded
- AMH 2012
- NBIX 1992
- Country
- AMH United States
- NBIX United States
- Employees
- AMH N/A
- NBIX N/A
- Industry
- AMH Real Estate Investment Trusts
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMH Real Estate
- NBIX Health Care
- Exchange
- AMH Nasdaq
- NBIX Nasdaq
- Market Cap
- AMH 11.8B
- NBIX 14.4B
- IPO Year
- AMH 2013
- NBIX 1996
- Fundamental
- Price
- AMH $32.08
- NBIX $144.77
- Analyst Decision
- AMH Buy
- NBIX Strong Buy
- Analyst Count
- AMH 15
- NBIX 18
- Target Price
- AMH $38.60
- NBIX $172.33
- AVG Volume (30 Days)
- AMH 3.2M
- NBIX 1.1M
- Earning Date
- AMH 10-29-2025
- NBIX 10-28-2025
- Dividend Yield
- AMH 3.75%
- NBIX N/A
- EPS Growth
- AMH 23.05
- NBIX 12.44
- EPS
- AMH 1.18
- NBIX 4.19
- Revenue
- AMH $1,831,836,000.00
- NBIX $2,682,700,000.00
- Revenue This Year
- AMH $8.06
- NBIX $23.68
- Revenue Next Year
- AMH $4.44
- NBIX $18.02
- P/E Ratio
- AMH $27.12
- NBIX $34.56
- Revenue Growth
- AMH 7.71
- NBIX 19.61
- 52 Week Low
- AMH $31.01
- NBIX $84.23
- 52 Week High
- AMH $39.49
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- AMH 46.34
- NBIX 50.90
- Support Level
- AMH $31.57
- NBIX $145.00
- Resistance Level
- AMH $32.48
- NBIX $148.84
- Average True Range (ATR)
- AMH 0.67
- NBIX 5.31
- MACD
- AMH 0.02
- NBIX -0.33
- Stochastic Oscillator
- AMH 43.59
- NBIX 47.17
About AMH American Homes 4 Rent of Beneficial Interest
American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.